Dr. Carolyn Myers on FendX Technologies’ Breakthrough Film Formulation that Kills and Repels Bacteria episode artwork

EPISODE · Dec 6, 2023 · 13 MIN

Dr. Carolyn Myers on FendX Technologies’ Breakthrough Film Formulation that Kills and Repels Bacteria

from Investor.News · host Investor.News

In an insightful interview with Tracy Weslosky from Investor.Coffee, Dr. Carolyn Myers, President, CEO, and Director of FendX Technologies Inc. (CSE: FNDX | OTCQB: FDXTF), shared significant advancements in nanotechnology relating to antimicrobial films. FendX, having licensed original technology from McMaster University in 2021, has developed a unique film formulation that both repels and kills bacteria. This breakthrough, achieved through collaboration with McMaster, involves using photoactive nanoparticles, titanium dioxide (TiO2), which not only serves as a linker in the chemical composition of the film surface but also exhibits killing properties when exposed to light. Dr. Myers highlighted the exceptional efficiency of this formulation, with the film showing nearly 100% repelling properties (99.8% precisely) and a 99.6% effectiveness in killing residual bacteria. This dual-action capability sets this formulation apart in the market, offering a potentially future superior alternative to existing films that either repel or kill pathogens. FendX’s current focus is on producing REPELWRAP™ film, which specializes in repelling bacteria and viruses. The film formulation referenced in the November 29, 2023, news release, is created by activating the substrate (i.e., plastic like Saran wrap), then coating it with TiO2 and fluorosilane followed by thermal shrinking creating a surface that significantly prevents bacterial adhesion. Dr. Myers contrasted FendX’s technology with other existing surface protection films that effectively kill microbes when they come in contact with the film surface, but this takes time leaving a potential window of opportunity for transmission before the bacteria are killed. In terms of applications, Dr. Myers emphasized the potential versatility of FendX’s technology, with the company developing both film and spray products. The primary application areas include healthcare and other high-traffic environments. The spray technology, still in early development, promises even broader applications due to its ease of application.

In an insightful interview with Tracy Weslosky from Investor.Coffee, Dr. Carolyn Myers, President, CEO, and Director of FendX Technologies Inc. (CSE: FNDX | OTCQB: FDXTF), shared significant advancements in nanotechnology relating to antimicrobial films. FendX, having licensed original technology from McMaster University in 2021, has developed a unique film formulation that both repels and kills bacteria. This breakthrough, achieved through collaboration with McMaster, involves using photoactive nanoparticles, titanium dioxide (TiO2), which not only serves as a linker in the chemical composition of the film surface but also exhibits killing properties when exposed to light. Dr. Myers highlighted the exceptional efficiency of this formulation, with the film showing nearly 100% repelling properties (99.8% precisely) and a 99.6% effectiveness in killing residual bacteria. This dual-action capability sets this formulation apart in the market, offering a potentially future superior alternative to existing films that either repel or kill pathogens. FendX’s current focus is on producing REPELWRAP™ film, which specializes in repelling bacteria and viruses. The film formulation referenced in the November 29, 2023, news release, is created by activating the substrate (i.e., plastic like Saran wrap), then coating it with TiO2 and fluorosilane followed by thermal shrinking creating a surface that significantly prevents bacterial adhesion. Dr. Myers contrasted FendX’s technology with other existing surface protection films that effectively kill microbes when they come in contact with the film surface, but this takes time leaving a potential window of opportunity for transmission before the bacteria are killed. In terms of applications, Dr. Myers emphasized the potential versatility of FendX’s technology, with the company developing both film and spray products. The primary application areas include healthcare and other high-traffic environments. The spray technology, still in early development, promises even broader applications due to its ease of application.

NOW PLAYING

Dr. Carolyn Myers on FendX Technologies’ Breakthrough Film Formulation that Kills and Repels Bacteria

0:00 13:26

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Investor.News?

This episode is 13 minutes long.

When was this Investor.News episode published?

This episode was published on December 6, 2023.

What is this episode about?

In an insightful interview with Tracy Weslosky from Investor.Coffee, Dr. Carolyn Myers, President, CEO, and Director of FendX Technologies Inc. (CSE: FNDX | OTCQB: FDXTF), shared significant advancements in nanotechnology relating to antimicrobial...

Can I download this Investor.News episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!